XTalks

OCTOBER 4, 2023

Health economics and outcomes research (HEOR) and market access strategies play a critical role in ensuring that newly approved therapies are made available to patients. Professionals in these roles are facing new challenges when it comes to negotiating coverage for many of the new, innovative treatments that are coming to market.

Marketing 105

Marketing Development Drugs Gene Therapy 105

pharmaphorum

SEPTEMBER 22, 2021

Family businesses across industries including the life sciences sector contribute significantly to the global economy – they represent about half of the world gross domestic product and global employment. In the life sciences sector, the overall goal is to develop and commercialise innovative pharmaceutical solutions to improve health.

Pharma Companies 111

Pharma Companies Life Science Development Production 111

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. Capturing market share. The combination of health and data, he passionately believes, will transform life sciences. billion in 2021 to $9.23

Marketing 98

Marketing Life Science Sales Branding 98

Drug Discovery World

MAY 6, 2024

Thanks to a prestigious academic legacy, Europe has long been a dominant region for life sciences. In this article, DDW’s Diana Spencer highlights several prominent hotspots that are taking the lead on advancing European drug discovery and development. respectively compared to an average market growth of 5.8%

Drugs 59

Drugs Life Science Gene Editing Gene 59

World of DTC Marketing

JANUARY 24, 2022

Venture capitalists have poured $42 billion into drug development over the past three years. Most small biotech companies rely on venture capitalist funding to develop new drugs but is that a good way to go? billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8

Life Science 225

Life Science Drugs Genetic Disease Development 225

Delveinsight

JULY 21, 2021

However, some of the key pharma companies at the global level have shifted their focus towards these diverse diseases. Through this article, we have covered the major autoimmune diseases and the key companies striving to transform the treatment landscape of the respective disease.

Pharma Companies 94

Pharma Companies Marketing Insulin Development 94

Drug Discovery World

FEBRUARY 10, 2023

DDW Editor Reece Armstrong explores the Scandinavian drug discovery sector and speaks to key players about Sweden’s place in the market. Scandinavia represents one of the most exciting but perhaps underrepresented markets for the discovery and development of pharmaceuticals.

Life Science 52

Life Science Drugs Gene Therapy Manufacturing 52

Drug Discovery World

OCTOBER 16, 2023

The United Kingdom has established itself as a hub for drug discovery expertise worldwide. There is a range of reasons why this area has become focal point for drug discovery, one of which is the fact that it encompasses the University of Oxford and the University of Cambridge, two of the oldest and most prestigious universities in the world.

Drugs 75

Drugs Life Science Gene Therapy Genome 75

pharmaphorum

SEPTEMBER 15, 2020

As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. This is reinforced by web-focused marketing strategies that give them a highly-targeted approach when it comes to marketing execution.”. Be more agile .

Branding 130

Branding Marketing Pharma Companies Life Science 130

XTalks

MAY 20, 2021

The pandemic has led to a rise in both TV watching and health awareness, which pharma companies took advantage of by increasing spending on TV commercials by about 17 percent overall. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Pharma Companies Development Drugs 52

Pharmaceutical Technology

AUGUST 1, 2022

Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. The shift from private to public funding enabled more rapid development of Covid-19 drugs and vaccines.

Vaccination 234

Vaccination Vaccine Bacteria Life Science 234

XTalks

SEPTEMBER 28, 2023

While digital media, such as short video formats on social media platforms, is being adopted by many segments and industries, pharma advertising remains more traditional, with print and TV advertising continuing to be favored by pharma companies. Outside of pharma, the list included new ads from Revlon and mobile games Dream.

Drugs 105

Drugs Allergies Branding FDA Approval 105

Drug Discovery World

APRIL 27, 2023

Megan Thomas takes a snapshot of the US biotech market and some of the ongoing research coming out of the US. In 2021, Savills put together a report on the regional hubs attracting science/pharma investment 1. The Boston Globe headline 3 , ‘Life sciences is poised to be Boston’s dominant industry.

Life Science 52

Life Science Drugs Research Gene Splicing 52

Pharmaceutical Technology

JANUARY 31, 2023

The US omnibus bill passed in late December 2022 will give the agency greater powers to regulate accelerated approval drugs, while the Inflation Reduction Act’s lowering of drug prices will create an uncertain environment for drug developers, he said. That leaves three years for pharma companies to prepare.

Drugs 130

Drugs Regulation Gene Therapy Insulin 130

XTalks

MAY 3, 2024

Healthcare company Real Chemistry announced its introduction of IRIS, an insights-as-a-service platform that will deliver all things related to GLP-1 drugs. This includes news on the obesity market, the latest info on current and future GLP-1 drugs and the overall growing influence of GLP-1 therapies. However, only 3.5

Drugs 52

Drugs Clinical Trials Clinical Trials Marketing 52

pharmaphorum

DECEMBER 14, 2022

Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. November saw the launch of a new private equity team in life sciences at J.P. Morgan Asset Management, dubbed Life Sciences Private Capital. New CEO joins UBC.

Life Science 98

Life Science Gene Therapy Gene Editing Gene 98

pharmaphorum

JANUARY 16, 2023

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the future of the scheme in its present form.

Life Science 69

Life Science Drugs Branding Medicine 69

Drug Discovery World

OCTOBER 6, 2022

As we start to look beyond the pandemic, which areas of Europe’s drug discovery community should we take note of? The European drug discovery sector is buoyant. With key players including AstraZeneca, Bayer, Novartis and Pfizer pushing the boundaries of drug development, the reason behind this growth is evident. Valued at $14.8

Development 52

Development Drugs Life Science Marketing 52

pharmaphorum

JUNE 9, 2021

At Fishawack Health, we are always seeking opportunities to enhance our capabilities and help our life science clients navigate the new, dynamically changing healthcare environment. Meet closerlook. The COVID-19 pandemic has highlighted the necessity of digital communication and the opportunities an omnichannel approach brings.

Marketing 72

Marketing Life Science Branding Production 72

pharmaphorum

JUNE 20, 2022

Paul Verdin, VP of consulting and analytics, and Andreas Hadjivasiliou, managing analyst at Evaluate, tell us about the company’s Orphan Drug Report 2022, which highlights activities within the orphan drug market and forecasts what the future of the industry holds based on data.

Drugs 52

Drugs Marketing Life Science Regulation 52

Drug Discovery World

DECEMBER 6, 2023

The industry has responded that these sales rebate levels have damaged the UK’s international standing with global life science companies and are likely to continue to negatively impact UK life sciences and NHS patients’ access to medicines. in Spain and 8.25% in Ireland.

Life Science 59

Life Science Branding Medicine Pharma Companies 59

World of DTC Marketing

JUNE 22, 2022

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Then there is the cost of generic drugs.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

Drug Discovery World

OCTOBER 9, 2023

Over twenty pharma companies have rejected the UK government’s proposed changes to the statutory scheme for branded medicines, the latest move in an ongoing disagreement between the government and industry. And will be “highly damaging to UK life sciences and NHS patients’ access to medicines”.

Medicine 52

Medicine Life Science Branding Pharma Companies 52

pharmaphorum

JANUARY 25, 2022

The Toronto-based company already counts many of the world’s largest pharma companies among its customers, using its platform for a range of tasks such as improving reagent and antibody selection to help scientists run more successful experiments, drawing on data from published studies and organisations’ internal databases.

Life Science 52

Life Science Pharma Companies Reagent Scientist 52

pharmaphorum

AUGUST 17, 2020

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Within this, the progressive pharma companies are utilising modular content to increase brand standards.

Regulation 97

Regulation Marketing Sales Branding 97

XTalks

DECEMBER 20, 2023

As we step into 2024, the life sciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables.

Life Science 119

Life Science Gene Editing Development Clinical Trials 119

pharmaphorum

APRIL 19, 2022

In 2022, pharma is truly a global industry, and innovation can come from anywhere. But for small life sciences outside of the USA and Europe, it can still be challenging to break onto this global stage. The company recently raised $16.5 So] we are trying to go for the international market.”. “In

Marketing 52

Marketing Clinical Trials Clinical Trials Licensing 52

Drug Discovery World

FEBRUARY 6, 2024

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. Quris-AI, which combines patient-on-a-chip, AI and real-time nano-sensing technologies to predict the safety and efficacy of drug candidates.

Marketing 69

Marketing Medicine Genome Genomics 69

pharmaphorum

NOVEMBER 30, 2022

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

Life Science 98

Life Science Pharma Companies Sales Marketing 98

Drug Discovery World

OCTOBER 18, 2022

The group will work closely with another member, the Sustainable Health Coalition (SHC), in support of its work with the Sustainable Markets Initiative (SMI). The CoI currently has 25 members from Japan, US, and Europe, including top 10 pharma companies, CROs, and academic representatives. Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

Drug Discovery World

OCTOBER 4, 2022

DDW Editor Reece Armstrong explores some of the trends that will be featured in sessions throughout ELRIG Drug Discovery 2022 and the news behind them. There’s no question that cell and gene therapies have emerged as some of the most promising and innovative medicines on the market. . Cell and gene therapies. Automation.

Gene Therapy 52

Gene Therapy Drugs Gene Manufacturing 52

XTalks

APRIL 16, 2024

Lady Gaga’s continuing partnership with Pfizer has yielded another video ad for the company’s migraine drug Nurtec ODT (Rimegepant). Watch the ad here: Lady Gaga’s Journey, The Next Chapter The ad opens with Gaga saying “Nothing dims my light like a migraine” and goes on to reveal how she found relief with migraine drug Nurtec ODT.

Drugs 52

Drugs Pharma Companies Doctors Doctor 52

Drug Discovery World

JANUARY 24, 2023

DDW Multimedia Editor Megan Thomas observes the 2023 drug discovery landscape, speaking to industry experts and looking at the foundations of 2022 on which next year will lean. The overall virtual clinical trials market is currently valued at $7.8 billion, with a projected growth of 14% per annum 1.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

pharmaphorum

DECEMBER 15, 2022

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. Healthcare Provider (HCP) marketing.

Clinical Trials 103

Clinical Trials Clinical Trials Life Science Marketing 103

XTalks

JUNE 25, 2024

In the past two years, the industry has faced considerable challenges due to a constrained financing environment, forcing many emerging and early-stage biotech companies to restructure their operations, merge with other companies or narrow their research and development (R&D) efforts by shelving certain assets. billion in 2023.

Pharma Companies 52

Pharma Companies Production FDA Approval Vaccination 52

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. But what does it take to implement these innovations? Mark holds a PhD in biomedicine, and an MSc in biostatistics.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

NOVEMBER 23, 2022

Innovative offerings around market access. A director in life sciences consulting for EY, she works within the commercial space for such companies, as well as their clients. “My I’ve always worked as a consultant for pricing and access strategies for clients, helping them to get drugs to market and access patients.

Life Science 98

Life Science Marketing Medicine Production 98